Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renaud Felten

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|May 13, 2021
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
Autoimmunity Reviews|April 3, 2020
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Philippe Mertz, Flora Sagez, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
The Lancet. Rheumatology|January 30, 2024
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measureSuzanne Arends, Liseth de Wolff, Jolien F van Nimwegen, et al.
Journal of Translational Autoimmunity|January 23, 2023
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infectionCloé Comarmond, Elodie Drumez, Julien Labreuche, et al.
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Rheumatology (Oxford, England)|May 11, 2021
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patientsDan Levy, Benoit Nespola, Margherita Giannini, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|May 13, 2021
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
Autoimmunity Reviews|April 3, 2020
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Philippe Mertz, Flora Sagez, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
The Lancet. Rheumatology|January 30, 2024
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measureSuzanne Arends, Liseth de Wolff, Jolien F van Nimwegen, et al.
Journal of Translational Autoimmunity|January 23, 2023
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infectionCloé Comarmond, Elodie Drumez, Julien Labreuche, et al.
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Rheumatology (Oxford, England)|May 11, 2021
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patientsDan Levy, Benoit Nespola, Margherita Giannini, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
Pageof 7